insights_auto
Why is AKTX down 7.49%?
Dive Deeperchevron_right
AKTX:NASDAQ
Akari Therapeutics PLC
$7.90
arrow_downward
-7.49%(-0.64) 1D
Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
$8.33
High
$8.70
Low
$7.90
Mkt. cap
18.05M
Avg. vol.
71.58K
Volume
0.00
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
Open
$8.33
High
$8.70
Low
$7.90
Mkt. cap
18.05M
Avg. vol.
71.58K
Volume
0.00
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
News stories
From web sources and news partners
www.marketscreener.com
·
14 hours ago
Akari Therapeutics, Plc Announces Appointment of Vatnak Vat-Ho as Chief Business Officer
The Manila Times
·
20 hours ago
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering
StreetInsider
·
20 hours ago
Akari Therapeutics names Vatnak Vat-Ho as chief business officer
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com